Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

111 - 120 of 4332 results found

Psychosis secondary to COVID-19 in pediatric sickle cell disease

Date
Wednesday, February 14, 2024 - 4:00 AM
Description
KEY CLINICAL MESSAGE: COVID-19 psychosis is a potential long-term sequela of COVID-19. Vulnerable populations, such as individuals with sickle cell disease, are at high risk for psychosis. Given the limited number of cases, more investigations in the

Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review

Date
Tuesday, February 13, 2024 - 4:00 AM
Description
CONCLUSIONS: Anti-SARS-CoV-2-antibodies are useful for early identification of high-risk patients and timely adjustment of therapy. Protective thresholds may be applied to advise booster vaccinations but verification in separate cohorts is required.